ImmuneOncia (424870.KQ) — Stock Score Summary

ImmuneOncia (424870.KQ) has a MoatMap StockRank of 3/100 based on Quality (27/100), Value (31/100), and Momentum (18/100) factor scores. The current signal is STRONG SELL.

ImmuneOncia Therapeutics, Inc., an immuno-oncology-centric biopharmaceutical company, develops immuno-oncology drugs for the treatment of cancer.

Key Financial Metrics

Price$2.73
Market Cap$252M
Price/Book11.68
Return on Equity-134.2%
Return on Invested Capital-94.7%
Debt/Equity0.24
Gross Margin76.7%
Operating Margin-49180.0%
Free Cash Flow$-10K

ImmuneOncia operates in the Biotechnology industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is ImmuneOncia’s (424870.KQ) StockRank?
MoatMap’s StockRank for ImmuneOncia (424870.KQ) is 3/100, with a Strong Sell signal. It is a composite of Quality (27), Value (31), and Momentum (18) factor ranks across MoatMap’s 19,000+ stock universe.
Does ImmuneOncia have an economic moat?
ImmuneOncia (424870.KQ) has a Quality factor score of 27/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is ImmuneOncia a buy, hold, or sell?
MoatMap’s current signal for ImmuneOncia (424870.KQ) is Strong Sell, based on a StockRank of 3/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is ImmuneOncia in?
ImmuneOncia (424870.KQ) operates in the Healthcare sector, specifically the Biotechnology industry (South Korea).
Browse all ranked stocks424870.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock